Association of Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence and State-Issued Nonpharmaceutical Interventions: United States, 1 August 2020 to 30 March 2021.

Maureen J MillerAustin HimschootNatalie FitchSucheta JawalkarDane FreemanCharity HiltonKevin BerneyGery P GuyTina J BenoitKristie E N ClarkeMichael P BuschJean D OpsomerSusan L StramerAron J HallAdi V GundlapalliAdam MacNeilRussell McCordGregory SunshineMara Howard-WilliamsChristopher DunphyJefferson M Jones

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)

Consistent with studies assessing NPIs relative to COVID-19 incidence and mortality, the presence of NPIs were associated with lower SARS-CoV-2 seroprevalence indicating lower rates of cumulative infections. Multiple NPIs are likely more effective than single NPIs.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
risk factors
physical activity
type diabetes
cardiovascular disease